NOVO NORDISK A/S-B (NONOF:OTCMKTS)
$37.69 -0.2637 (-0.6948%)
Analysed NOVO NORDISK A/S-B (NONOF:OTCMKTS) News Sources
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
13-10-2026
fool.com
The Zacks Analyst Blog Highlights Walmart, Visa, Novo Nordisk, Village Super Market and Empire Petroleum
14-10-2026
yahoo.com
Ablexis Announce License Agreement with Novo
14-10-2026
yahoo.com
Viking’s Key Obesity Pill Enters Phase 3 Trial – Here’s What Investors Need To Know
14-10-2026
stocktwits.com
Is Novo Nordisk (NYSE:NVO) A Long Term Value Opportunity Now?
14-10-2026
yahoo.com
Roche Expands Obesity Pipeline With Rona's RNAi Candidate
14-10-2026
yahoo.com
Novo Nordisk (NVO) Could Be 63% Undervalued Following Its Share Buyback
14-10-2026
yahoo.com
Walmart to increase employee benefits with new initiative for 2027
15-10-2026
thestreet.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
15-10-2026
yahoo.com
Viking Therapeutics Starts Phase III Development of Obesity Pill
15-10-2026
yahoo.com
What is the current price of NOVO NORDISK A/S-B (NONOF:OTCMKTS)?
The current price of NOVO NORDISK A/S-B (NONOF:OTCMKTS) is $37.69.
NOVO NORDISK A/S-B (NONOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NOVO NORDISK A/S-B (NONOF:OTCMKTS) since the previous trading day is $-0.2637.
NOVO NORDISK A/S-B (NONOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NOVO NORDISK A/S-B (NONOF:OTCMKTS) since the previous trading day is -0.6948%.
What is the most recent average sentiment score for NOVO NORDISK A/S-B (NONOF:OTCMKTS)?
The most recent average sentiment score for NOVO NORDISK A/S-B (NONOF:OTCMKTS) is 54 out of 100.
What is the most recent average sentiment for NOVO NORDISK A/S-B (NONOF:OTCMKTS)?
The most recent sentiment for NOVO NORDISK A/S-B (NONOF:OTCMKTS) is .
SEC-8K** Filing Available For NOVO NORDISK A/S-B (NONOF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.